Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP538221.RAQyiINNIRBKtYUQk5z6NpKZPXgzRIcJafvQiC0x1NGzY130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538221.RAQyiINNIRBKtYUQk5z6NpKZPXgzRIcJafvQiC0x1NGzY130_provenance.
• NP275256.RAEzfI4pa4q5x4CPlKo21PTCYnXGOdODnqVcYBWdN7JEI130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP275256.RAEzfI4pa4q5x4CPlKo21PTCYnXGOdODnqVcYBWdN7JEI130_provenance.
• NP245989.RABwO_ZNzDr54ZIBU1lojjQ0IQf4UdCt8XShskyEqmv1A130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245989.RABwO_ZNzDr54ZIBU1lojjQ0IQf4UdCt8XShskyEqmv1A130_provenance.
• NP552629.RACRqrN7DX_-7GAVM-OIZjkaOz3NCKdfwdblhNKNm5syA130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552629.RACRqrN7DX_-7GAVM-OIZjkaOz3NCKdfwdblhNKNm5syA130_provenance.
• NP859888.RAqETZ5VcprL3VcCYnBxofagyB9eJNzYU_avTrwQfq87w130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859888.RAqETZ5VcprL3VcCYnBxofagyB9eJNzYU_avTrwQfq87w130_provenance.
• NP426665.RAqlHlCpcS8epn9Vjcfh2Ta4h0CxTOPATyavP4qOUWy4w130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426665.RAqlHlCpcS8epn9Vjcfh2Ta4h0CxTOPATyavP4qOUWy4w130_provenance.
• NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449531.RAgOHoFMxSiEOGuvN5ULUStD3Ndj5mvz1v-hbUDAqb464130_provenance.
• assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP390014.RA6nigG_XeBpkeIhiGiextmiYL1hC4NHBetGFQC3NlE_U130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390014.RA6nigG_XeBpkeIhiGiextmiYL1hC4NHBetGFQC3NlE_U130_provenance.
• NP649591.RA9Gj7gs8FIqYl9VbsAt09TItdGOC5jsGLuKI-QVlVVUo130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649591.RA9Gj7gs8FIqYl9VbsAt09TItdGOC5jsGLuKI-QVlVVUo130_provenance.
• NP347107.RAT2_Q7jB8iigOwRj28IvZJvGARNWvECBjtUe9lRKd7Y4130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347107.RAT2_Q7jB8iigOwRj28IvZJvGARNWvECBjtUe9lRKd7Y4130_provenance.
• assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP861981.RAoZ3hNf4QsAAcV2CZgZXEDMRA_iAxL5l8oPAc94wnnvE130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861981.RAoZ3hNf4QsAAcV2CZgZXEDMRA_iAxL5l8oPAc94wnnvE130_provenance.
• NP566977.RAARPgylR_tsDuBm6ff5MOAoEOgesoKx6_6q_iGEdu9-s130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566977.RAARPgylR_tsDuBm6ff5MOAoEOgesoKx6_6q_iGEdu9-s130_provenance.
• NP566969.RAhEfzSwGhn4fyQDqG6QbaxWOntqNhhlU2rTDRapgLRro130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566969.RAhEfzSwGhn4fyQDqG6QbaxWOntqNhhlU2rTDRapgLRro130_provenance.
• NP566972.RAmgBVZz2UrfM5_S9WqctANKenqHzgN7aYmOuOJ6Vg9ps130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566972.RAmgBVZz2UrfM5_S9WqctANKenqHzgN7aYmOuOJ6Vg9ps130_provenance.
• NP347102.RAMgGU14Ian4exfWV8j_33amHgWYXFAg7fAiODmFCMVEU130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347102.RAMgGU14Ian4exfWV8j_33amHgWYXFAg7fAiODmFCMVEU130_provenance.
• NP654371.RA50VkcWS512FkJYicTjJGPly8YZkLOYr-Te_3oX4Iicw130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654371.RA50VkcWS512FkJYicTjJGPly8YZkLOYr-Te_3oX4Iicw130_provenance.
• NP566975.RAGEx2PKlVskcOfOXY4DdjpWFHuOoHF-qBhHjgjjhKUsU130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566975.RAGEx2PKlVskcOfOXY4DdjpWFHuOoHF-qBhHjgjjhKUsU130_provenance.
• NP566971.RAy8PqCNCw6vcMKXhvodPDILHDLwE7ifWqOVPzovQErTM130_assertion description "[For example, methylation of PTEN and RASSF1A genes occurs mostly in follicular thyroid cancer, and its tumorigenic role may be related to the phosphatidylinositol 3-kinase/Akt signaling pathway, whereas methylation of genes for tissue inhibitor of metalloproteinase-3, SLC5A8, and death-associated protein kinase occurs in papillary thyroid cancer and is related to the BRAF/MAPK kinase/MAPK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566971.RAy8PqCNCw6vcMKXhvodPDILHDLwE7ifWqOVPzovQErTM130_provenance.